233 related articles for article (PubMed ID: 30240326)
1. New Approaches to the Management of Adult Acute Lymphoblastic Leukemia.
Bassan R; Bourquin JP; DeAngelo DJ; Chiaretti S
J Clin Oncol; 2018 Sep; ():JCO2017773648. PubMed ID: 30240326
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Managing Acute Lymphoblastic Leukemia.
DeAngelo DJ; Jabbour E; Advani A
Am Soc Clin Oncol Educ Book; 2020 May; 40():330-342. PubMed ID: 32421447
[TBL] [Abstract][Full Text] [Related]
3. New approaches to the treatment of older adults with acute lymphoblastic leukemia.
Schwartz M; Wieduwilt MJ
Semin Hematol; 2020 Jul; 57(3):122-129. PubMed ID: 33256901
[TBL] [Abstract][Full Text] [Related]
4. Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020.
Rank CU; Schmiegelow K
Semin Hematol; 2020 Jul; 57(3):102-114. PubMed ID: 33256899
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia.
Hefazi M; Litzow MR
Blood Lymphat Cancer; 2018; 8():47-61. PubMed ID: 31360093
[TBL] [Abstract][Full Text] [Related]
6. Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum.
Curran E; Muffly L; Luskin MR
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35503981
[TBL] [Abstract][Full Text] [Related]
7. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
8. Continuing challenges and current issues in acute lymphoblastic leukemia.
Kansagra A; Dahiya S; Litzow M
Leuk Lymphoma; 2018 Mar; 59(3):526-541. PubMed ID: 28604239
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-From Intensive Chemotherapy Combinations to Chemotherapy-Free Regimens: A Review.
Jabbour E; Haddad FG; Short NJ; Kantarjian H
JAMA Oncol; 2022 Sep; 8(9):1340-1348. PubMed ID: 35834222
[TBL] [Abstract][Full Text] [Related]
10. Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy.
Aldoss I; Gu Z; Afkhami M; Mokhtari S; Pullarkat V
Leuk Lymphoma; 2023 Jun; 64(6):1092-1101. PubMed ID: 37021793
[TBL] [Abstract][Full Text] [Related]
11. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
Jabbour E; Pui CH; Kantarjian H
JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220
[TBL] [Abstract][Full Text] [Related]
12. The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.
Jabbour E; Short NJ; Jain N; Haddad FG; Welch MA; Ravandi F; Kantarjian H
J Hematol Oncol; 2023 Mar; 16(1):22. PubMed ID: 36927623
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.
Aldoss IT; Marcucci G; Pullarkat V
Oncology (Williston Park); 2016 Dec; 30(12):1080-91. PubMed ID: 27987201
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Adult Acute Lymphoblastic Leukemia.
Richard-Carpentier G; Kantarjian H; Jabbour E
Curr Hematol Malig Rep; 2019 Apr; 14(2):106-118. PubMed ID: 30879177
[TBL] [Abstract][Full Text] [Related]
15. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
Wolach O; Amitai I; DeAngelo DJ
Br J Haematol; 2017 Dec; 179(5):705-723. PubMed ID: 29076138
[TBL] [Abstract][Full Text] [Related]
16. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of acute lymphoblastic leukemia.
Rafei H; Kantarjian HM; Jabbour EJ
Leuk Lymphoma; 2019 Nov; 60(11):2606-2621. PubMed ID: 31092071
[TBL] [Abstract][Full Text] [Related]
18. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.
Martinelli G; Boissel N; Chevallier P; Ottmann O; Gökbuget N; Topp MS; Fielding AK; Rambaldi A; Ritchie EK; Papayannidis C; Sterling LR; Benjamin J; Stein A
J Clin Oncol; 2017 Jun; 35(16):1795-1802. PubMed ID: 28355115
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xie M; Shi T; Jiang Q; Jia Y; Zhou D; Tong H; Jin J; Zhu HH
Cancer; 2023 May; 129(10):1523-1536. PubMed ID: 36882308
[TBL] [Abstract][Full Text] [Related]
20. How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
Zhang M; Huang H
Front Immunol; 2020; 11():611710. PubMed ID: 33384696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
